两家公司宣布,合并后的公司更名为“tras Pharma, Inc.”,由新任首席执行官Werner Cautreels领导,将于周三在纳斯达克上市交易,股票代码为“TRAW”。
TRAW即将到来的里程碑包括在2024年下半年开始...查看全文
$Onconova医疗(ONTX)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-19-066050 Act: 33 Size: 548 KB 网页链接
$Onconova医疗(ONTX)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-19-066039 Act: 34 Size: 294 KB 网页链接
$Onconova医疗(ONTX)$ 8-K Current report, item 3.01 Accession Number: 0001104659-19-065505 Act: 34 Size: 28 KB 网页链接
$Onconova医疗(ONTX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000905718-19-000947 Act: 34 Size: 37 KB 网页链接
$Onconova医疗(ONTX)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-19-063513 Act: 33 Size: 1 MB 网页链接
$Onconova医疗(ONTX)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-19-062752 Act: 33 Size: 1 MB 网页链接
$Onconova医疗(ONTX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001104659-19-062715 Act: 34 Size: 7 MB 网页链接
$Onconova医疗(ONTX)$ S-1 - General form for registration of securities under the Securities Act of 1933 Filed: 2019-10-29 AccNo: 0001104659-19-057049 Size: 592 KB 网页链接
$Onconova医疗(ONTX)$ 8-K - Current report Filed: 2019-10-24 AccNo: 0001104659-19-055985 Size: 49 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Onconova医疗(ONTX)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-09-27 AccNo: 0001535610-19-000097 Size: 15 KB 网页链接